-- European Stocks Advance; Peugeot, BASF Gain as Home Retail Sinks
-- B y   J u l i e   C r u z
-- 2010-10-20T16:19:47Z
-- http://www.bloomberg.com/news/2010-10-20/european-stock-futures-decline-as-rio-tinto-drops-on-australian-investment.html
European stocks advanced as
companies from PSA Peugeot Citroen to BASF SE reported earnings
that beat analysts’ estimates, offsetting declines in  Home
Retail Group Plc  and  Stada Arzneimittel AG .  Peugeot climbed 0.9 percent as the carmaker said quarterly
revenue grew and raised its full-year outlook. BASF rose 2.6
percent after the world’s biggest chemicals maker said
recovering markets helped lift its third-quarter profit beyond
analysts’ estimates. Home Retail dropped 2.4 percent after
reporting a decrease in first-half profit. Stada fell 3.7
percent as CA Cheuvreux cut its stance on the stock.  The  Stoxx 600 Index  added 0.3 percent to 266.13 as of 4:30
p.m. in London after swinging between gains and losses at least
nine times. The  Stoxx 600  has rallied 2.5 percent this month
amid speculation that the policy makers at the U.S. Federal
Reserve will announce another round of asset purchases at their
November meeting in a bid to jumpstart economic growth.  “The outlook for 2011 is not brilliant, but is not bad
either,” said  Philipp Musil , who helps oversee about $10
billion at Semper Constantia Privatbank AG in Vienna. “I hope
the market won’t be dissatisfied with the Fed’s quantitative
easing program in November, but the market is still in good
shape.”  Earnings Season  Of the 20 companies in the Stoxx 600 that have announced
results since Oct. 7, 15 have beaten  analyst estimates  for per-
share income, according to data compiled by Bloomberg. In the
U.S., 62 of the 74 Standard & Poor’s 500 Index companies that
have announced results this earnings season have topped
predictions,  the data  show. Analysts predict 24 percent growth
in third-quarter profit from a year earlier for S&P 500
companies, a fourth straight increase, Bloomberg data show.  National benchmark indexes increased in 15 of the 18
western European markets today. The U.K.’s FTSE 100 Index gained
0.4 percent and Germany’s DAX Index rose 0.5 percent. France’s
CAC 40 Index increased 0.6 percent.  Novo Nordisk A/S , the world’s biggest insulin maker, surged
9.1 percent to 538 kroner, the largest jump since October 2008.
The U.S. Food and Drug Administration yesterday said that Amylin
Pharmaceuticals Inc., Eli Lilly & Co. and Alkermes Inc. must
conduct a new study of their drug, delaying its debut by as much
as 20 months.  Rio Tinto Group  gained 2.7 percent to 4,056 pence, the
first advance this week. The world’s third-largest mining
company said it will spend $3.1 billion increasing the capacity
of its iron ore infrastructure in the Pilbara region of Western
Australia to 283 million metric tons by 2013. Rio made the
announcement two days after abandoning a joint venture with  BHP
Billiton Ltd.  to combine their Pilbara operations to save $10
billion.  Peugeot, BASF Rise  Peugeot added 0.9 percent to 27.66 euros. Third-quarter
sales advanced to 13 billion euros ($18.2 billion) from 11.8
billion euros a year earlier, the Paris-based company said
today. Analysts had predicted sales of 12.3 billion euros, the
average of seven estimates compiled by Bloomberg.  BASF  rose 2.6 percent to 51.93 euros after raising its
full-year outlook, following third-quarter profit that beat
analysts’ estimates. The company forecast 2010 sales of about 63
billion euros and earnings before interest and taxes and special
items of more than 8 billion euros.  Stagecoach, National Express  Stagecoach Group Plc and National Express Group Plc surged
9.4 percent to 205.1 pence and 4.7 percent to 249.4 pence,
respectively, as the U.K. government retained bus subsidies amid
the country’s deepest-ever budget cuts.  FirstGroup Plc , which runs the Thameslink train service in
London, increased 6.4 percent to 401.5 pence.  BIC SA  gained 3.8 percent to 63.76 euros, its highest price
since July 1998. The maker of ballpoint pens reported a 26
percent increase in third-quarter profit to 61.1 million euros,
outpacing a 19 percent gain in sales.  Gamesa Corporacion Tecnologica SA  gained 5.6 percent to
4.96 euros. Iberdrola SA, Spain’s biggest utility, said it will
“probably” continue buying shares in wind turbine maker
Gamesa. “We think the stock is cheap,” Chief Executive Officer
 Jose Ignacio Sanchez Galan  said on a conference call after
increasing the stake to 15.24 percent today.  Heidelberger Druckmaschinen AG  soared 7.3 percent to 3.44
euros, the highest price in two weeks. The world’s largest maker
of printing presses said second-quarter sales rose to 633
million euros from 499 million euros. The operating loss
narrowed to 5 million euros to 10 million euros.  Waertsilae Gains  Waertsilae Oyj  gained 6.6 percent to 49.17 euros as the
Finnish maker of ship engines and power plants reported third-
quarter net income of 101 million euros beating the 55.1
million-euro mean estimate of five analysts surveyed by
Bloomberg.  United Internet AG  advanced 4.7 percent to 12.40 euros.
BofA Merrill Lynch Global Research reinstated coverage of the
German Internet service provider with a “buy” recommendation.  Faurecia  sank 5.3 percent to 18.50 euros as Europe’s
largest maker of car interiors said One Equity Partners, a unit
of JPMorgan, sold a 13 percent stake in the French company in a
share placement at 18.20 euros apiece.  Home Retail  lost 2.4 percent to 214.7 pence after it said
in a statement today that first-half pretax profit declined 23
percent to 94.7 million pounds ($150 million) as cash-strapped
consumers spent less on furniture and video games at its Argos
unit and it offered discounts to drive sales.  Vestas Wind Systems A/S , the world’s largest maker of wind
turbines, slumped 4.6 percent to 198.10 kroner. Hansen
Transmissions International NV, a maker of wind-turbine
gearboxes, plunged 14 percent to 43.5 pence after saying it
expects sales to decline this fiscal year.  Stada Arzneimittel  dropped 3.7 percent to 22.29 euros as
Cheuvreux cut its recommendation on the German generic-drug
maker to “underperform” from “outperform,” citing one-off
charges in Serbia and slower growth in Germany.  To contact the reporter on this story:
 Julie Cruz  in Frankfurt at 
 jcruz6@bloomberg.net .  To contact the editor responsible for this story:
David Merritt at   dmerritt1@bloomberg.net . 